UFP Industries Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
UFP Industries Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 | 2023-09-30 | 2023-07-01 | 2023-04-01 | 2022-09-24 | 2022-06-25 | 2022-03-26 | 2021-09-25 | 2021-06-26 | 2021-03-27 | 2020-09-26 | 2020-06-27 | 2020-03-28 | 2019-09-28 | 2019-06-29 | 2019-03-30 | 2018-09-29 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-07-01 | 2017-04-01 | 2016-09-24 | 2016-06-25 | 2016-03-26 | 2015-09-26 | 2015-06-27 | 2015-03-28 | 2014-09-27 | 2014-06-28 | 2014-03-29 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||||||||||||
net earnings | 100,871,000 | 79,423,000 | 69,783,000 | 101,619,000 | 126,232,000 | 121,099,000 | 134,183,000 | 150,788,000 | 125,578,000 | 172,101,000 | 207,853,000 | 193,131,000 | 125,747,000 | 175,360,000 | 104,251,000 | 78,861,000 | 69,694,000 | 40,570,000 | 52,581,000 | 55,145,000 | 36,002,000 | 42,066,000 | 45,132,000 | 33,582,000 | 34,668,000 | 34,575,000 | 21,634,000 | 28,764,000 | 34,238,000 | 20,255,000 | 26,883,000 | 26,884,000 | 10,804,000 | 20,492,000 | 22,447,000 | 7,668,000 |
adjustments to reconcile net earnings to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||
depreciation | 34,000,000 | 32,941,000 | 32,511,000 | 31,487,000 | 30,624,000 | 30,019,000 | 27,646,000 | 27,012,000 | 25,774,000 | 24,847,000 | 22,192,000 | 21,842,000 | 23,399,000 | 19,609,000 | 18,733,000 | 15,896,000 | 15,613,000 | 15,717,000 | 15,452,000 | 14,725,000 | 14,475,000 | 14,346,000 | 13,432,000 | 12,712,000 | 12,762,000 | 11,856,000 | 11,392,000 | 9,836,000 | 9,686,000 | 9,492,000 | 9,607,000 | 9,410,000 | 8,996,000 | 8,597,000 | 7,953,000 | 7,691,000 |
amortization of intangibles | 5,928,000 | 5,817,000 | 5,900,000 | 5,886,000 | 5,853,000 | 5,882,000 | 4,954,000 | 5,362,000 | 5,009,000 | 4,708,000 | 4,068,000 | 4,672,000 | 2,176,000 | 3,195,000 | 3,998,000 | 2,734,000 | 1,558,000 | 1,571,000 | 1,744,000 | 1,094,000 | 1,852,000 | 1,572,000 | 1,474,000 | 1,228,000 | 1,172,000 | 1,258,000 | 1,119,000 | 583,000 | 592,000 | 693,000 | 842,000 | 905,000 | 983,000 | 549,000 | 608,000 | 586,000 |
expense associated with share-based and grant compensation arrangements | 8,809,000 | 11,561,000 | 10,818,000 | 8,069,000 | 7,999,000 | 11,277,000 | 8,193,000 | 8,238,000 | 9,637,000 | 7,437,000 | 5,611,000 | 6,931,000 | 2,702,000 | 2,761,000 | 2,981,000 | 849,000 | 859,000 | 1,444,000 | 896,000 | 922,000 | 1,287,000 | 838,000 | 830,000 | 1,094,000 | ||||||||||||
deferred income taxes | -209,000 | -17,000 | -14,708,000 | -973,000 | 180,000 | 119,000 | 432,000 | -77,000 | -242,000 | -448,000 | 78,000 | 101,000 | -771,000 | 35,000 | 142,000 | -180,000 | 4,000 | 286,000 | -18,000 | -46,000 | -519,000 | -238,000 | 131,000 | 224,000 | -108,000 | -272,000 | 196,000 | -193,000 | 81,000 | 196,000 | -150,000 | |||||
unrealized gain on investments and other | -1,326,000 | 672,000 | 305,000 | -2,130,000 | 2,272,000 | 4,580,000 | 1,601,000 | |||||||||||||||||||||||||||||
equity in (earnings) loss of investee | ||||||||||||||||||||||||||||||||||||
net income on sale, disposition and impairment of assets | ||||||||||||||||||||||||||||||||||||
gain from reduction of estimated earnout liability | -1,511,000 | -344,000 | -605,000 | 0 | ||||||||||||||||||||||||||||||||
changes in: | ||||||||||||||||||||||||||||||||||||
accounts receivable | 27,305,000 | -211,709,000 | 149,425,000 | 74,484,000 | -12,226,000 | -164,613,000 | 100,834,000 | 7,347,000 | -191,064,000 | 167,108,000 | 48,213,000 | -352,928,000 | 195,006,000 | -82,771,000 | -253,323,000 | -55,684,000 | -61,301,000 | -94,253,000 | 11,627,000 | -38,752,000 | -100,716,000 | 34,599,000 | -55,901,000 | -99,765,000 | -20,449,000 | -33,473,000 | -67,766,000 | 25,841,000 | -30,922,000 | -64,276,000 | 28,206,000 | -41,781,000 | -63,148,000 | 29,053,000 | -43,870,000 | -61,825,000 |
inventories | 36,291,000 | -33,830,000 | -74,882,000 | 39,554,000 | 59,472,000 | -17,788,000 | 76,146,000 | 139,739,000 | 14,674,000 | 98,394,000 | 123,366,000 | -258,019,000 | 125,433,000 | -121,809,000 | -207,768,000 | -65,150,000 | 51,766,000 | -25,783,000 | 52,170,000 | 51,657,000 | -23,649,000 | 22,380,000 | -4,425,000 | -57,403,000 | 26,159,000 | 34,005,000 | -60,984,000 | 14,119,000 | 29,723,000 | -22,159,000 | 41,262,000 | 74,228,000 | -64,422,000 | 3,978,000 | 34,756,000 | -23,980,000 |
accounts payable and cash overdraft | -20,015,000 | 52,902,000 | -14,997,000 | -23,734,000 | 8,861,000 | 52,264,000 | -7,806,000 | -11,489,000 | 68,388,000 | -67,367,000 | -87,775,000 | 143,895,000 | -89,581,000 | 21,126,000 | 121,892,000 | 28,337,000 | 36,970,000 | 20,047,000 | -35,654,000 | 24,891,000 | 25,056,000 | -24,054,000 | 22,730,000 | 39,935,000 | 15,278,000 | 5,377,000 | 32,769,000 | 3,706,000 | 9,822,000 | 21,498,000 | -34,934,000 | 579,000 | 45,219,000 | -22,265,000 | ||
accrued liabilities and other | 28,785,000 | -46,166,000 | -23,537,000 | 23,944,000 | 27,567,000 | -53,290,000 | 44,779,000 | 31,963,000 | -95,105,000 | 32,803,000 | 5,153,000 | -6,466,000 | 20,316,000 | 64,661,000 | 14,090,000 | 33,155,000 | 80,894,000 | -8,648,000 | 27,089,000 | 17,258,000 | -7,924,000 | 5,466,000 | 24,397,000 | -8,502,000 | 12,154,000 | 31,743,000 | -9,676,000 | 12,974,000 | 16,121,000 | 4,318,000 | 12,342,000 | 16,745,000 | 10,880,000 | 9,309,000 | 26,194,000 | -2,743,000 |
net cash from operating activities | 221,945,000 | -108,807,000 | 144,909,000 | 258,584,000 | 255,876,000 | -16,798,000 | 390,739,000 | 358,140,000 | -37,076,000 | 442,649,000 | 335,428,000 | -245,031,000 | 397,496,000 | 80,927,000 | -196,660,000 | 37,873,000 | 193,371,000 | -46,161,000 | 127,132,000 | 126,777,000 | -55,829,000 | 96,173,000 | 48,100,000 | -84,172,000 | 82,139,000 | 85,951,000 | -70,740,000 | 96,336,000 | 69,998,000 | -29,957,000 | 84,587,000 | 87,367,000 | -50,545,000 | 47,724,000 | 77,536,000 | -54,732,000 |
capex | -62,484,000 | -67,268,000 | -66,781,000 | -58,908,000 | -57,437,000 | -49,148,000 | -45,966,000 | -46,815,000 | -38,166,000 | -42,050,000 | -39,603,000 | -32,072,000 | -31,064,000 | -44,372,000 | -34,656,000 | -20,294,000 | -19,444,000 | -27,286,000 | -23,861,000 | -26,594,000 | -15,883,000 | -20,228,000 | -29,951,000 | -24,362,000 | -22,640,000 | -18,018,000 | -16,531,000 | -11,454,000 | -11,328,000 | -12,941,000 | -8,764,000 | -12,654,000 | -15,102,000 | -11,576,000 | -11,106,000 | -8,994,000 |
free cash flows | 159,461,000 | -176,075,000 | 78,128,000 | 199,676,000 | 198,439,000 | -65,946,000 | 344,773,000 | 311,325,000 | -75,242,000 | 400,599,000 | 295,825,000 | -277,103,000 | 366,432,000 | 36,555,000 | -231,316,000 | 17,579,000 | 173,927,000 | -73,447,000 | 103,271,000 | 100,183,000 | -71,712,000 | 75,945,000 | 18,149,000 | -108,534,000 | 59,499,000 | 67,933,000 | -87,271,000 | 84,882,000 | 58,670,000 | -42,898,000 | 75,823,000 | 74,713,000 | -65,647,000 | 36,148,000 | 66,430,000 | -63,726,000 |
cash flows used in investing activities: | ||||||||||||||||||||||||||||||||||||
purchases of property, plant and equipment | -62,484,000 | -67,268,000 | -66,781,000 | -58,908,000 | -57,437,000 | -49,148,000 | -45,966,000 | -46,815,000 | -38,166,000 | -42,050,000 | -39,603,000 | -32,072,000 | -31,064,000 | -44,372,000 | -34,656,000 | -20,294,000 | -19,444,000 | -27,286,000 | -23,861,000 | -26,594,000 | -15,883,000 | -20,228,000 | -29,951,000 | -24,362,000 | -22,640,000 | -18,018,000 | -16,531,000 | -11,454,000 | -11,328,000 | -12,941,000 | -8,764,000 | -12,654,000 | -15,102,000 | -11,576,000 | -11,106,000 | -8,994,000 |
proceeds from sale of property, plant and equipment | 2,936,000 | 758,000 | 7,706,000 | 1,442,000 | 1,009,000 | 1,344,000 | 1,422,000 | 470,000 | 319,000 | 274,000 | 822,000 | 1,207,000 | 19,924,000 | 1,611,000 | 5,062,000 | 1,944,000 | 235,000 | 409,000 | 203,000 | 736,000 | 241,000 | 888,000 | 474,000 | 36,250,000 | 1,082,000 | 686,000 | 353,000 | 207,000 | 177,000 | 132,000 | 1,297,000 | 1,035,000 | 50,000 | 4,709,000 | 969,000 | 785,000 |
acquisitions, net of cash received and purchase of equity method investment | -11,971,000 | -3,735,000 | -52,555,000 | |||||||||||||||||||||||||||||||||
purchases of investments | -9,682,000 | -7,191,000 | -21,113,000 | -17,868,000 | -7,064,000 | -9,352,000 | -11,586,000 | -3,038,000 | -11,709,000 | -1,759,000 | -9,136,000 | -6,030,000 | -3,285,000 | -5,843,000 | -8,738,000 | -4,172,000 | -6,042,000 | -14,052,000 | -1,616,000 | -4,410,000 | -449,000 | -3,053,000 | -2,630,000 | -6,718,000 | 2,963,000 | -14,299,000 | -819,000 | -897,000 | ||||||||
proceeds from sale of investments | 5,163,000 | 2,304,000 | 17,062,000 | 4,498,000 | 4,984,000 | 4,300,000 | 10,615,000 | 2,637,000 | 8,849,000 | 1,815,000 | 3,496,000 | 4,725,000 | 2,972,000 | 3,504,000 | 3,381,000 | 3,942,000 | 7,079,000 | 11,260,000 | 492,000 | 3,327,000 | 340,000 | 118,000 | -1,865,000 | 5,045,000 | -3,020,000 | 6,043,000 | 1,204,000 | 494,000 | ||||||||
other | 2,009,000 | -418,000 | -306,000 | 12,386,000 | -4,468,000 | -3,206,000 | -4,168,000 | 3,227,000 | -1,151,000 | 3,740,000 | 166,000 | -2,995,000 | -2,770,000 | -294,000 | -414,000 | -4,000 | 372,000 | -54,000 | 209,000 | -210,000 | 200,000 | 732,000 | -758,000 | -594,000 | 41,000 | -267,000 | 142,000 | -997,000 | -563,000 | -173,000 | 238,000 | -42,000 | -16,000 | 40,000 | -99,000 | -36,000 |
net cash from investing activities | -74,029,000 | -75,550,000 | -93,262,000 | -58,450,000 | -62,976,000 | -56,062,000 | -102,238,000 | -43,452,000 | -41,858,000 | -103,849,000 | -59,027,000 | -59,736,000 | -14,259,000 | -217,500,000 | -296,498,000 | -34,715,000 | -18,002,000 | -48,210,000 | -58,249,000 | -32,185,000 | -15,551,000 | -22,546,000 | -64,373,000 | 1,304,000 | -21,488,000 | -29,288,000 | -70,599,000 | -170,776,000 | -16,300,000 | -13,386,000 | -13,208,000 | -13,457,000 | -13,441,000 | -5,674,000 | -13,590,000 | -14,425,000 |
cash flows used in financing activities: | ||||||||||||||||||||||||||||||||||||
borrowings under revolving credit facilities | 8,559,000 | 4,798,000 | 9,783,000 | 7,776,000 | 7,254,000 | 5,100,000 | 7,889,000 | 6,589,000 | 4,437,000 | 0 | 327,750,000 | 242,950,000 | 37,022,000 | 613,664,000 | 236,280,000 | 103,000 | 0 | 6,759,000 | 28,030,000 | 155,874,000 | 237,560,000 | 147,945,000 | 192,511,000 | 296,342,000 | 165,437,000 | 163,511,000 | 281,090,000 | 49,317,000 | 1,927,000 | 1,235,000 | 37,620,000 | 119,431,000 | 140,303,000 | 2,174,000 | 83,983,000 | 106,318,000 |
repayments under revolving credit facilities | -8,062,000 | -4,752,000 | -11,779,000 | -8,489,000 | -7,710,000 | -4,278,000 | -10,060,000 | -7,351,000 | -4,518,000 | 0 | -429,637,000 | -141,438,000 | -298,640,000 | -468,125,000 | -121,570,000 | 0 | 0 | -6,498,000 | -52,510,000 | -234,795,000 | -173,232,000 | -237,284,000 | -252,228,000 | -179,429,000 | -224,518,000 | -211,544,000 | -137,767,000 | -23,967,000 | -1,715,000 | -1,495,000 | -75,260,000 | -183,275,000 | -52,718,000 | -12,568,000 | -132,360,000 | -47,547,000 |
repayment of debt on behalf of investee | 0 | 0 | 0 | -6,303,000 | ||||||||||||||||||||||||||||||||
contingent consideration payments and other | 0 | -221,000 | -89,000 | 0 | -1,000,000 | -3,779,000 | 0 | 0 | -6,179,000 | -11,000 | -2,002,000 | -551,000 | -1,200,000 | -837,000 | -627,000 | |||||||||||||||||||||
proceeds from issuance of common stock | 644,000 | 650,000 | 689,000 | 652,000 | 816,000 | 654,000 | 639,000 | 763,000 | 685,000 | 653,000 | 794,000 | 663,000 | 583,000 | 573,000 | 363,000 | 345,000 | 378,000 | 319,000 | 270,000 | 281,000 | 261,000 | 256,000 | 294,000 | 206,000 | 145,000 | 185,000 | 146,000 | 106,000 | 160,000 | 130,000 | 236,000 | 255,000 | 469,000 | 96,000 | 102,000 | 99,000 |
dividends paid to shareholders | -20,656,000 | -21,322,000 | -20,061,000 | -20,061,000 | -20,249,000 | -20,411,000 | -18,574,000 | -15,507,000 | -15,642,000 | -15,405,000 | -15,474,000 | -12,541,000 | -9,281,000 | -9,276,000 | -9,274,000 | -7,646,000 | -7,644,000 | -7,730,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | ||||||||||||
distributions to noncontrolling interest | 0 | -2,448,000 | -6,069,000 | -3,331,000 | -2,496,000 | 0 | -4,859,000 | -9,970,000 | 0 | -2,053,000 | 0 | 0 | -2,914,000 | -633,000 | 0 | -299,000 | -734,000 | -400,000 | -500,000 | -1,161,000 | -303,000 | -775,000 | -1,319,000 | -280,000 | -1,673,000 | -1,429,000 | -561,000 | -1,170,000 | -1,909,000 | -311,000 | -939,000 | -609,000 | -400,000 | -701,000 | ||
payments to taxing authorities in connection with shares directly withheld from employees | -13,000 | -9,547,000 | 0 | 0 | 0 | -17,838,000 | ||||||||||||||||||||||||||||||
repurchase of common stock | -191,380,000 | -60,553,000 | 2,000 | -21,760,000 | -100,564,000 | -18,798,000 | -6,592,000 | -22,196,000 | -33,288,000 | -2,410,000 | -90,304,000 | -501,000 | 0 | 0 | -29,212,000 | -24,000 | -971,000 | -848,000 | -3,042,000 | -9,851,000 | -83,000 | -723,000 | 1,000 | -78,000 | ||||||||||||
net cash from financing activities | -211,412,000 | -90,926,000 | -61,437,000 | -49,215,000 | -127,500,000 | -68,968,000 | -29,177,000 | 86,330,000 | -271,519,000 | 135,999,000 | 101,927,000 | 142,150,000 | -7,249,000 | -39,723,000 | -24,968,000 | -91,324,000 | 61,069,000 | -91,038,000 | 3,270,000 | 111,570,000 | -63,291,000 | -67,176,000 | 141,697,000 | -40,038,000 | -71,916,000 | 87,028,000 | -15,679,000 | -52,890,000 | 58,161,000 | |||||||
effect of exchange rate changes on cash | 1,864,000 | 312,000 | -2,184,000 | -1,453,000 | -3,805,000 | 79,000 | -1,380,000 | 1,840,000 | 2,739,000 | -1,095,000 | -770,000 | 1,726,000 | -404,000 | 461,000 | -349,000 | 300,000 | 297,000 | -1,719,000 | -209,000 | 118,000 | 248,000 | 503,000 | -489,000 | 233,000 | 59,000 | 314,000 | 882,000 | -408,000 | -518,000 | -43,000 | -724,000 | -126,000 | -154,000 | -187,000 | 16,000 | -76,000 |
net change in cash and cash equivalents | -61,632,000 | -274,971,000 | -11,974,000 | 149,466,000 | 61,595,000 | -141,749,000 | 257,944,000 | 278,849,000 | -135,563,000 | 311,064,000 | 64,288,000 | -216,711,000 | 111,314,000 | -113,000 | -391,580,000 | 145,608,000 | 168,417,000 | -135,813,000 | 43,706,000 | 3,386,000 | -10,063,000 | -16,908,000 | -13,492,000 | 28,935,000 | -2,581,000 | -10,199,000 | 1,240,000 | -50,834,000 | 44,452,000 | -44,691,000 | 30,617,000 | 1,868,000 | 22,888,000 | -11,072,000 | ||
cash, cash equivalents, and restricted cash, beginning of year | 0 | 1,179,594,000 | 0 | 0 | 0 | 1,122,256,000 | 0 | 0 | 559,623,000 | 0 | 0 | 291,223,000 | 0 | 0 | 436,608,000 | 0 | 0 | 168,666,000 | 0 | 0 | 28,198,000 | 0 | 0 | 28,816,000 | 0 | 0 | 34,489,000 | |||||||||
cash, cash equivalents, and restricted cash, end of period | -61,632,000 | 904,623,000 | -11,974,000 | 149,466,000 | 61,595,000 | 980,507,000 | 257,944,000 | 278,849,000 | 424,060,000 | 311,064,000 | 64,288,000 | 74,512,000 | 111,314,000 | -113,000 | 45,028,000 | 145,608,000 | 168,417,000 | 32,853,000 | 43,706,000 | 3,386,000 | 18,135,000 | -16,908,000 | -13,492,000 | 57,751,000 | -2,581,000 | -10,199,000 | 35,729,000 | |||||||||
reconciliation of cash and cash equivalents and restricted cash: | ||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 1,171,828,000 | 0 | 0 | 0 | 1,118,329,000 | 0 | 0 | 559,397,000 | 0 | 0 | 286,662,000 | 0 | 0 | 436,507,000 | 0 | 0 | 168,336,000 | 0 | 0 | 27,316,000 | 0 | 0 | 28,339,000 | 0 | 0 | 34,091,000 | |||||||||
restricted cash, beginning of period | 0 | 7,766,000 | 0 | 0 | 0 | 3,927,000 | 0 | 0 | 226,000 | 0 | 0 | 4,561,000 | 0 | 0 | 101,000 | 0 | 0 | 330,000 | 0 | 0 | 882,000 | 0 | 0 | 477,000 | 0 | 0 | 398,000 | |||||||||
cash, cash equivalents, and restricted cash, beginning of period | 0 | 1,179,594,000 | 0 | 0 | 0 | 1,122,256,000 | 0 | 0 | 559,623,000 | 0 | 0 | 291,223,000 | 0 | 0 | 436,608,000 | 0 | 0 | 168,666,000 | 0 | 0 | 28,198,000 | 0 | 0 | 28,816,000 | 0 | 0 | 34,489,000 | |||||||||
cash and cash equivalents, end of period | -61,632,000 | 903,562,000 | -18,979,000 | 149,466,000 | 61,595,000 | 979,746,000 | 254,944,000 | 278,849,000 | 423,299,000 | 311,064,000 | 64,288,000 | 73,783,000 | 94,351,000 | -113,000 | 44,399,000 | 145,608,000 | 168,417,000 | 32,129,000 | 44,001,000 | 3,386,000 | 17,111,000 | -1,174,000 | 2,175,000 | 25,326,000 | -2,581,000 | -6,395,000 | 31,020,000 | -50,834,000 | 44,452,000 | 43,065,000 | 30,617,000 | 1,868,000 | 22,888,000 | |||
restricted cash, end of period | 0 | 1,061,000 | 7,005,000 | 0 | 0 | 761,000 | 3,000,000 | 0 | 761,000 | 0 | 0 | 729,000 | 16,963,000 | 0 | 629,000 | 0 | 0 | 724,000 | -295,000 | 0 | 1,024,000 | -15,734,000 | -15,667,000 | 32,425,000 | 0 | -3,804,000 | 4,709,000 | |||||||||
supplemental information: | ||||||||||||||||||||||||||||||||||||
interest paid | 2,352,000 | 3,038,000 | 3,521,000 | 2,924,000 | 3,218,000 | 3,099,000 | 3,147,000 | 3,036,000 | 3,309,000 | 2,989,000 | 4,112,000 | 2,896,000 | 3,253,000 | 4,413,000 | 2,694,000 | 319,000 | 3,419,000 | 374,000 | 629,000 | 4,088,000 | 570,000 | 1,066,000 | 3,046,000 | 843,000 | 861,000 | 2,552,000 | 497,000 | 367,000 | 1,865,000 | 355,000 | 404,000 | 2,056,000 | 374,000 | 320,000 | 1,874,000 | 281,000 |
income taxes paid | 51,084,000 | 2,496,000 | 15,844,000 | 46,699,000 | 63,794,000 | 1,778,000 | 52,074,000 | 62,191,000 | 4,138,000 | 74,697,000 | 136,720,000 | 1,700,000 | 63,719,000 | 72,925,000 | 249,000 | 45,523,000 | -529,000 | 2,307,000 | 18,537,000 | 11,768,000 | 2,801,000 | 19,930,000 | 17,500,000 | 1,245,000 | 18,213,000 | 13,558,000 | 2,337,000 | 23,595,000 | 23,929,000 | 11,084,000 | -9,709,000 | 20,073,000 | 4,851,000 | 1,681,000 | ||
non-cash investing activities: | ||||||||||||||||||||||||||||||||||||
capital expenditures included in accounts payable | -445,000 | 1,770,000 | 1,926,000 | -1,446,000 | -346,000 | 3,351,000 | 1,512,000 | -1,207,000 | 3,122,000 | 355,000 | 344,000 | 2,512,000 | ||||||||||||||||||||||||
non-cash financing activities: | ||||||||||||||||||||||||||||||||||||
common stock issued under deferred compensation plans | 1,085,000 | 8,823,000 | 1,067,000 | 1,110,000 | 1,127,000 | 8,616,000 | 1,008,000 | 979,000 | 7,950,000 | 861,000 | 858,000 | 6,705,000 | 714,000 | 705,000 | 5,359,000 | 657,000 | 638,000 | 4,900,000 | 579,000 | 584,000 | 4,457,000 | 533,000 | 542,000 | 4,237,000 | 442,000 | 438,000 | 3,793,000 | 282,000 | 420,000 | 2,955,000 | 314,000 | 202,000 | 2,526,000 | 148,000 | 228,000 | 1,894,000 |
cash flows used in operating activities: | ||||||||||||||||||||||||||||||||||||
equity in loss of investee | 19,000 | 77,000 | 642,000 | 594,000 | 8,000 | 417,000 | 588,000 | |||||||||||||||||||||||||||||
net gain on sale, disposition and impairment of assets | -76,000 | -860,000 | -453,000 | |||||||||||||||||||||||||||||||||
unrealized (gain) loss on investments and other | 1,984,000 | -1,142,000 | -149,000 | -1,030,000 | -1,754,000 | |||||||||||||||||||||||||||||||
impairment of goodwill and other intangibles | ||||||||||||||||||||||||||||||||||||
repayments of debt | 0 | 0 | -29,000 | 528,000 | -2,286,000 | -199,000 | ||||||||||||||||||||||||||||||
purchase of remaining noncontrolling interest of subsidiary | 0 | 0 | ||||||||||||||||||||||||||||||||||
net gain on sale and disposition of assets | -231,000 | -164,000 | -414,000 | 1,072,000 | -306,000 | -8,905,000 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
non-cash investing activities | ||||||||||||||||||||||||||||||||||||
unrealized loss on investments and other | ||||||||||||||||||||||||||||||||||||
net (gain) loss on sale and disposition of assets | -283,000 | |||||||||||||||||||||||||||||||||||
cash flows (used in) from financing activities: | ||||||||||||||||||||||||||||||||||||
net cash (used in) from financing activities | -59,368,000 | -8,728,000 | -1,305,000 | |||||||||||||||||||||||||||||||||
cash flows from (used in) operating activities: | ||||||||||||||||||||||||||||||||||||
equity in earnings of investee | 1,017,000 | 515,000 | 946,000 | 835,000 | 630,000 | 1,000 | -49,000 | -111,000 | -81,000 | -88,000 | -112,000 | -83,000 | -117,000 | -78,000 | -51,000 | |||||||||||||||||||||
acquisitions and purchases of non-controlling interest, net of cash received | -14,772,000 | -24,571,000 | -36,000 | -172,106,000 | -261,133,000 | -16,131,000 | -202,000 | -18,487,000 | ||||||||||||||||||||||||||||
cash flows from investing activities: | ||||||||||||||||||||||||||||||||||||
cash flows from financing activities: | ||||||||||||||||||||||||||||||||||||
issuance of long-term debt | 0 | |||||||||||||||||||||||||||||||||||
net gain on disposition of assets | -532,000 | -199,000 | -122,000 | 477,000 | -6,534,000 | |||||||||||||||||||||||||||||||
unrealized gain on investments | -554,000 | -93,000 | -170,000 | -1,348,000 | ||||||||||||||||||||||||||||||||
net (gain) loss on disposition of assets and impairment of assets | ||||||||||||||||||||||||||||||||||||
contingent consideration payment and other | ||||||||||||||||||||||||||||||||||||
net gain on disposition of assets and impairment of assets | 14,000 | -285,000 | ||||||||||||||||||||||||||||||||||
repayment of debt | -3,000 | -3,074,000 | -38,000 | -32,000 | -3,029,000 | -74,000 | -205,000 | -5,232,000 | ||||||||||||||||||||||||||||
unrealized (gain) loss on investments | 3,173,000 | |||||||||||||||||||||||||||||||||||
investment in life insurance contracts | ||||||||||||||||||||||||||||||||||||
deferred income taxes credits | 169,000 | 206,000 | -742,000 | |||||||||||||||||||||||||||||||||
acquisitions, net of cash received | -33,676,000 | -1,003,000 | -29,173,000 | -8,787,000 | -201,000 | -64,933,000 | 0 | 1,000 | -2,585,000 | 0 | -2,944,000 | -4,191,000 | ||||||||||||||||||||||||
borrowings of debt | -712,000 | 263,000 | 1,376,000 | |||||||||||||||||||||||||||||||||
net (gain) on disposition of assets and impairment of assets | ||||||||||||||||||||||||||||||||||||
advances of notes receivable | -12,000 | -6,000 | 0 | -228,000 | -2,454,000 | -1,687,000 | -1,259,000 | -1,320,000 | -1,810,000 | -1,273,000 | 1,058,000 | -825,000 | -2,462,000 | |||||||||||||||||||||||
collections on notes receivable | 482,000 | 293,000 | 320,000 | 721,000 | 2,088,000 | 2,323,000 | 1,408,000 | 1,725,000 | 1,269,000 | 5,790,000 | 95,000 | 415,000 | 473,000 | |||||||||||||||||||||||
expense associated with share-based compensation arrangements | 696,000 | 711,000 | 571,000 | 591,000 | 545,000 | 432,000 | 477,000 | 496,000 | 378,000 | 513,000 | 437,000 | 495,000 | ||||||||||||||||||||||||
expense associated with stock grant plans | 45,000 | 53,000 | 46,000 | 35,000 | 33,000 | 37,000 | 32,000 | 26,000 | 27,000 | 23,000 | 29,000 | 29,000 | ||||||||||||||||||||||||
net (gain) loss on disposition and impairment of assets | -10,000 | |||||||||||||||||||||||||||||||||||
repayments of debt of acquiree | ||||||||||||||||||||||||||||||||||||
purchase of remaining noncontrolling interest, net of cash received | ||||||||||||||||||||||||||||||||||||
cash contributed from noncontrolling interest | 0 | |||||||||||||||||||||||||||||||||||
net income on disposition and impairment of assets | -264,000 | -64,000 | ||||||||||||||||||||||||||||||||||
acquisitions and purchase of noncontrolling interest, net of cash received | -55,441,000 | |||||||||||||||||||||||||||||||||||
excess tax benefits from share-based compensation arrangements | 0 | |||||||||||||||||||||||||||||||||||
cash restricted as to use | 0 | 230,000 | -553,000 | -429,000 | 0 | -305,000 | ||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of year | 0 | 0 | 87,756,000 | -1,079,000 | ||||||||||||||||||||||||||||||||
notes receivable exchanged for property | 0 | 0 | 389,000 | |||||||||||||||||||||||||||||||||
property exchanged for notes receivable | ||||||||||||||||||||||||||||||||||||
acquisition earnout adjustment prior to final purchase accounting | ||||||||||||||||||||||||||||||||||||
net gain on disposition and impairment of assets | 230,000 | |||||||||||||||||||||||||||||||||||
deferred income tax credit | -156,000 | |||||||||||||||||||||||||||||||||||
income taxes refunded | -4,080,000 | |||||||||||||||||||||||||||||||||||
purchase of remaining noncontrolling interest in subsidiary | 0 | |||||||||||||||||||||||||||||||||||
debt issuance costs | -2,000 | 0 | -9,000 | -2,000 | ||||||||||||||||||||||||||||||||
other receivables exchanged for notes receivable | 0 | 0 | 2,768,000 | |||||||||||||||||||||||||||||||||
adjustments to reconcile net earnings attributable to controlling interest: | ||||||||||||||||||||||||||||||||||||
net (gain) loss on sale of impairment of property, plant and equipment | 14,000 | |||||||||||||||||||||||||||||||||||
net gain on sale of property, plant and equipment | -329,000 | -602,000 | ||||||||||||||||||||||||||||||||||
accounts payable | 18,150,000 | |||||||||||||||||||||||||||||||||||
cash (cash overdraft), end of period | -12,151,000 |
We provide you with 20 years of cash flow statements for UFP Industries stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of UFP Industries stock. Explore the full financial landscape of UFP Industries stock with our expertly curated income statements.
The information provided in this report about UFP Industries stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.